Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Drop in Short Interest

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totaling 37 shares, a decline of 96.4% from the June 30th total of 1,033 shares. Based on an average trading volume of 7,749 shares, the short-interest ratio is presently 0.0 days.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. One analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Carl Zeiss Meditec currently has a consensus rating of “Hold”.

Carl Zeiss Meditec Stock Up 1.1%

Shares of CZMWY traded up $0.33 during mid-day trading on Friday, hitting $31.40. The company’s stock had a trading volume of 650 shares, compared to its average volume of 4,705. The firm has a 50-day simple moving average of $30.96 and a 200 day simple moving average of $32.20. Carl Zeiss Meditec has a 1-year low of $26.65 and a 1-year high of $60.10.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.